Stock Quote

Elan Corp PLC (ELN.I) (Irish Stock Exchange)
As of  6:06am EST
4.13EUR
Price Change
-0.18
Percent Change
-4.18%
 
€4.13
6:06am EST
-4.18%
€4.31
€4.15
46,538
€4.20
€4.11
€7.00
€3.15
0.88
322,271

Research Another Stock: Symbol Look-up
Elan, Biogen change Tysabri label due to PML risk
Saturday, 7 Nov 2009 10:34am EST 
J&J slashing workforce
Tuesday, 3 Nov 2009 02:41pm EST 
J&J to slash 7,000 to 8,000 jobs
Tuesday, 3 Nov 2009 02:06pm EST 
4 Platform Drugmakers to Invest In
Tuesday, 24 Nov 2009 10:15am EST(The Motley Fool) 
Thursday Options Recap
Thursday, 12 Nov 2009 04:18pm EST(Seeking Alpha) 
Cramer's Lightning Round - The Only Water Stock Worth Buying (11/10/09)
Wednesday, 11 Nov 2009 07:22am EST(Seeking Alpha) 
'Mad Money Lightning Round': Buy Bucyrus on Weakness
Tuesday, 10 Nov 2009 07:35pm EST(The Street) 
Nice Quarter, Teva. What Will You Buy Next?
Tuesday, 3 Nov 2009 10:31am EST(The Motley Fool) 
 
Name Current Position Compensation
McLaughlin, Kyran Non-Executive Chairman of the Board 300,000
Martin, G. Kelly Chief Executive Officer, Executive Director 830,496
Paya, Carlos President --

Profile

Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. Its principal research and development, manufacturing and marketing facilities are located in Ireland and the United States. Elan’s operations are organized into two business units: Biopharmaceuticals and Elan Drug... Full Description

Company Address

Elan Corp PLC
Treasury Building
Lower Grand Canal Street
Dublin     2
P: +3531.7094000
F: +3531.7094108

Analyst Research

  ELN.I Industry
P/E(TTM) -- 3.60
P/S(TTM) 4.73 0.57
ROI(TTM) -3.03 1.86
ROE(TTM) -- 2.52
Consensus Recommendation Outperform
EPS Est. (Current Period) 0.00
EPS Est. (Current Year) -0.40
Total Revenue $257.30M
Net Income $-110.59M
EPS $-0.23